Components like proper PPE, Lockout/Tagout and clear hazard communication are essential to implementing “safety first” practices.
Assessing risk level and ensuring workers have proper PPE are key steps to maintaining construction worker safety during this time.
During unplanned chemical releases, there are bound to be more questions than answers. Plume models are the best way to answer these questions and more.
OH&S has been celebrating innovation and products optimized to keep workers safe for over 10 years.
The NSC released a statement of approval in response to a workplace safety expert’s appointment to President-elect Joe Biden’s coronavirus task force.
Employing these techniques can be the difference between a safe, routine maintenance activity and a serious injury.
Your guide to choosing the best winter work gloves.
Hand protection for workers during chilly and windy environments should not be a second thought, as cold stress can lead to several hazardous conditions.
Management Commitment pertains to high level leadership’s “direct participation” in an organization’s EHS program.
There’s no official checklist or cheat sheet to make sure hearing testing is an effortless experience—some things come with experience and time.
OSHA provides a guide for employers to follow in order to keep their employees safe from coronavirus infection and the winter elements.
Investing in machine learning, the internet of things (IoT), and artificial intelligence (AI) to improve operational excellence, provide better customer experience, and ultimately grow a company’s bottom line isn’t a new idea.
A well-thought-out and well-organized emergency response plan will help prevent fatalities, reduce equipment maintenance costs and help mitigate potential environmental hazards.
Join Editor Sydny Shepard as she discusses the HHS guidelines on drug testing, the latest injury rates for the Meat Packing and Processing industry and how OSHA is suggesting retailers, delivery workers and those in order fulfillment decrease their risk of transmitting COVID-19.
As several biotechnology and pharmaceutical companies begin to apply for and receive emergency use authorization from the Federal Drug Administration (FDA) for their COVID-19 vaccines, the U.S. Centers for Disease Control and Prevention (CDC) has activated the distribution phase of its Operation Warp Speed Strategy for Distributing a COVID-19 Vaccine.
Interested in how to create an effective FR/AR program that works globally? Tune in as Editor Sydny Shepard talks with Paul Castelli, Westex's International Sales Director, about standards and certifications that transcend location.
Safety comes first when hosting gatherings for Thanksgiving this year.
To manage effectively, management needs information which tells them in real time how well the organizational systems are meeting business challenges, customer needs, innovation and growth.
OSHA provides resources for employers and employees to defer to for the upcoming holiday season.
Research collected from recovered coronavirus patients suggests long term immunity to the virus is possible.
On this Safety Speak episode of the podcast, we will discuss a new grant supporting research for the health and safety of correctional workers, a new OSHA guidance on ventilation for workplaces and how the CDC recommends you spend your Thanksgiving.
The NSC projects record high roadway fatalities during the four-day Thanksgiving holiday period.
The pandemic led several companies to begin producing PPE in order to fill a large void in availability.
The first at-home COVID-19 test will soon be available for $50.
The updated FAQ addresses the question of whether cloth face masks qualify as PPE.
A Washington state construction company was fined $92,000 after failing to enforce fall protection use among employees.
Sustainability is a hot topic, but does it have any real meaning for industrial PPE?
The incidence rate at meatpacking plants was only four per 100 workers in 2019.
With the possible implementation of hair testing for truck drivers, the OOIDA argues that it is ineffective and costly.
Moderna Inc. claims that its COVID-19 vaccine is 94.5% effective—a higher rate than Pfizer’s vaccine.